60 filings
8-K
HOOK
Hookipa Pharma Inc
18 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:03pm
8-K
HOOK
Hookipa Pharma Inc
4 Jun 24
HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society for Clinical Oncology 2024 Annual Meeting
4:15pm
8-K
HOOK
Hookipa Pharma Inc
23 May 24
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting
5:05pm
8-K
HOOK
Hookipa Pharma Inc
9 May 24
Results of Operations and Financial Condition
7:03am
8-K
HOOK
Hookipa Pharma Inc
25 Apr 24
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
7:10am
8-K
upnlmf
22 Mar 24
Results of Operations and Financial Condition
7:08am
8-K
5uc4l rigwyabr
31 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
v1vhotomonbva21n
29 Jan 24
HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs
8:12am
8-K
nboy8 cgw
21 Dec 23
HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
7:06am
8-K
rnj4u2 4570plwfjb4
1 Dec 23
Departure of Directors or Certain Officers
4:46pm
8-K
8tv7e 33bj2co6
9 Nov 23
Results of Operations and Financial Condition
7:05am
8-K
3tsqgrb2b3kr7w vbb9
20 Oct 23
Departure of Directors or Certain Officers
4:05pm
8-K
s6o9653kfhd6
13 Sep 23
HOOKIPA announces executive leadership change
8:47am
8-K
bg5xvvp0l108ku169w7j
10 Aug 23
Results of Operations and Financial Condition
7:05am
8-K
y55wk6y
4 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
8-K
pw4r7sucpu lr6e2gzr
9 Jun 23
Submission of Matters to a Vote of Security Holders
5:17pm
8-K
dtdwqob ncy8c2l
1 Jun 23
HOOKIPA Pharma Announces Pricing of $50.0 Million Public Offering of Common Stock and Non-Voting Convertible Preferred Stock
7:37pm
8-K
3401mq fxsog
31 May 23
HOOKIPA Pharma Announces Positive Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab in Patients with HPV16+ Head and Neck Cancers
5:24pm
8-K
qo4ojw69 zk39pf
11 May 23
Results of Operations and Financial Condition
7:03am
8-K
mz6aek d7qskc
13 Apr 23
Departure of Directors or Certain Officers
4:03pm